AUTHOR | TYPE AND STUDY POPULATION | SPECIMEN | MAIN miRNAS INVESTIGATED | MiRNAs ANALYSIS METHOD | CHIEF FINDING |
GUO D, et al. [20] | 67 CASES (CAD PATIENTS), 28 CONTROLS (NON-CAD) | PLASMA | miR 145 | RT-qPCR | HIGHER IN CAD PATIENTS |
FITCHLSCHERER et al. [21] | 8 CASES (STABLE CAD PATIENTS), 20 CONTROLS (NON-CAD) | PLASMA AND SERUM | miR-208a, miR-133, miR-145, miR-155, miR-17, miR-126, miR-92a | RT-qPCR | miR-208a, miR-133-[HIGHER IN CAD PATIENTS], miR-145, miR-155, miR-17, miR-126, miR-92a [LOWER IN CAD PATIENTS] |
LIU H, YANG N, FEI Z, et al. [22] | 95 CASES (CAD PATIENTS), 50 CONTROLS (NON-CAD) | PLASMA | miR-208a, miR-370 | RT-qPCR | HIGHER IN CAD PATIENTS |
WEBER et al. [23] | 10 CASES (CAD PATIENTS), 15 CONTROLS (NON-CAD) | WHOLE BLOOD SAMPLE | miR-145, miR-19a, miR-484, miR-155, miR-150, miR-378 | RT-qPCR | LOWER IN CAD PATIENTS |
LIU F et al. [24] | 81 CASES (CAD PATIENTS), 50 CONTROLS (NON-CAD) | PLASMA | miR-18a, miR-92a, miR-106b, miR-17 | RT-qPCR | miR-17 HIGHER IN CAD PATIENTS WITH INCREASED LIPID PROFILE, miR-92a, miR-106b LOWER IN CAD PATIENTS WITH INCREASED LIPID PROFILE. |
MINAMI et al. [26] | 44CASES (STABLE CAD PATIENTS), 22 CONTROLS (NON-CAD) | PLASMA | miR-221, miR-222 | RT-qPCR | HIGHER IN CAD PATIENTS |
ZHANG et al. [27] | 149 CASES (STABLE CAD PATIENTS), 22 CONTROLS (NON-CAD) | PLASMA | miR-6090, miR-4516 | RT-qPCR | miR-6090, miR-4516 CAN BE USED AS REFERENCE GENES FOR PLASMA miRNAs ANALYSIS IN STABLE CAD. |